Title of project or programme

An Optimized Person Centred Intervention to Improve Mental Health and Reduce Antipsychotics amongst People with Dementia in Care Homes

Principal Investigators of project/programme grant
Title Forname Surname Institution Country
Professor Clive Ballard Oxfordshire and Buckinghamshire Mental Health NHS Foundation Trust UK
Address of institution of lead PI
Institution Oxfordshire and Buckinghamshire Mental Health NHS Foundation Trust
Street Address 4000 John Smith Drive Oxford Business Park
City South Oxford
Postcode OX4 2GX
Country

United Kingdom

Source of funding information

Department of Health (DH)

Total sum awarded (Euro)

2321709

Start date of award

01/01/2010

Total duration of award in months

48

The project/programme is most relevant to
  • Alzheimer’s disease and other dementias
Keywords
Research abstract in English

250,000 people with dementia in the UK live in care homes. These individuals have complex mental health problems, disabilities and social needs, compounded by widespread prescription of sedative drugs. The inconsistent quality of care, the poor management of mental health problems and the widespread overuse of sedative drugs are matters for serious concern. The launch of the National Dementia Strategy (2009) and a parallel Department of Health report (2009) regarding the use of sedative drugs provides an opportunity to move forward on a national basis to provide a better trained workforce that can improve the mental health of people with dementia living in care homes and reduce the use of sedative drugs. Our optimized programme (WHELD) will determine the most effective elements of existing approaches to develop a comprehensive but practical intervention. This will be achieved by training care staff to provide care that is focused on an understanding of the individual and their needs; and by using additional components such as exercise, activities and social interaction to improve mental health, reduce the use of sedative drugs and improve quality of life (QOL). The value of these specific components will be established in a 9 month factorial study in 16 care homes. Each care home will receive Person Centred Care training either alone or in combination with the specific additional elements described above. This will enable us to optimize the intervention and develop it further for a large randomised controlled trial (RCT) against usual care. In parallel, we will complete a qualitative study to identify and overcome the potential barriers to enable effective implementation of the intervention. The overarching goal is to provide an effective, simple and practical intervention, which improves the mental health of, and reduces sedative drug use in, people with dementia in care homes; which can be rolled out nationally.

Lay summary

    Principal Investigators

    Professor Clive Ballard

    Institution

    Oxford Health NHS Foundation Trust

    Contact information of lead PI

    Country

    United Kingdom

    Title of project or programme

    An Optimized Person Centred Intervention to Improve Mental Health and Reduce Antipsychotics amongst People with Dementia in Care Homes

    Source of funding information

    NIHR (PGfAR Competition 5 Full)

    Total sum awarded (Euro)

    € 2,860,479

    Start date of award

    01/04/2010

    Total duration of award in years

    6.0

    The project/programme is most relevant to:

    Alzheimer's disease and other dementias

    Keywords

    Research Abstract

    Aims and objectives: To improve mental health and reduce the prescription of antipsychotic drugs for people with dementia in care homes, by developing and evaluating an optimized intervention based upon the most effective currently available therapies that can provide a broad range of benefits and which can be routinely implemented as part of NHS care. We will also determine whether the intervention improves quality of life (QOL).

    Background: There are 250,000 people with dementia in care homes in the UK. The mental health of these individuals, the high level of antipsychotic use and the variable quality of care are serious concerns. Key studies have reported specific interventions which either improve mental health or reduce antipsychotics, but no interventions achieved both of these goals and none improved QOL. In addition, no interventions have been widely implemented in routine practice.

    Research Plan

    Work Plan 1 A systematic review to update information on effective interventions. .

    Work Plan 2 Optimize interventions and Adapt for NHS context.

    The four interventions with established efficacy are:

    (1) Person Centred Care
    (2) Antipsychotic review
    (3) Social Interaction
    (4) Exercise

    Work plan 3 Incremental Evaluation of Key Interventions

    A 4 month period of evaluation will elucidate the breadth of benefits conferred by Person Centred Care, the incremental benefits added each of the other therapies and the cost consequence.

    Work Plan 4 Developing an Optimized intervention

    We will use a Delphi consensus process to develop the most effective, practical and cost-effective intervention to promote Wellbeing and Health in people with Dementia (WHELD) based upon Work Plans 2 and 3. A manual will be compiled.
    .
    Work Plan 5 Field Testing and RCT

    Ongoing field testing will address practical implementation issues as an NHS intervention in 12 care homes over an extended period. Qualitative studies will identify and address obstacles to implementation.

    A well powered cluster randomized controlled trial of the WHELD intervention will be undertaken over 12 months in 40 care homes involving 1000 people with dementia.

    Work Plan 6: Dissemination

    Dissemination tools will include written materials, web and new media, scientific publications and presentations, workshops and a roadshow; with follow-up meetings with commissioners, health and care professionals.

    Research team The applicants have innovated high quality clinical research focusing upon psychological interventions for people with dementia and clinical trials in care homes. This is supplemented by consumer involvement, world class health economic, qualitative and statistical expertise and a core input from individuals with NHS management roles.

    Programme Management Overall programme management will be coordinated by the Programme Management Group (PMG), chaired by Professor Bob Woods. Each work plan will have a management group convened by the Work Plan lead. Additional work groups will be convened for specific tasks and report back to the PMG. An independent trial steering group will oversee the RCT.

    Reseach Environment The host NHS Trust has innovated psychological services to older people, was the lead NHS partner in FITS and has a DENDRON centre providing an excellent infrastructure for clinical research. King’s College London/Institute of psychiatry, is a centre of excellence for dementia research with an MRC centre for neurodegeneration and an NHS Biomedical Research Centre. The partner universities (University College London, Bangor, Hull) are all leaders in psychological interventions for people with dementia and coordinate NIHR programmes.

    Anticipated Output The programme will deliver an an effective and practical NHS therapy to improve mental health and wellbeing and reduce the use of antipsychotic drugs in people with dementia living in care homes. The intervention (WHELD), will be underpinned by an operationalized mannual with a standardized training programme and a dissemination mechanism to enable effective implementation.

    Patient and Public Involvement The Alzheimer’s Society developed the FITS intervention. Consumer’s from the Alzheimer’s Society will play an active role in the development of mannuals, monitoring of evaluations and the dissemination programme.

    Ethical Implications All residents in the care homes will receive the benefits of any interventions. The research component will be the evaluation. For particpants without the capacity to consent, consent will be obtained from the next of kin or appointed guardian and best practice will ensure that the rights of potential participants are fully protected.

    Justification of resources requested: The requested resources are almost £2m. The programme will deliver a series of work plans including a large RCT of 1000 people with dementia, extensive field testing and a comprehensive dissemination plan, requiring considerable staff input.

    Lay Summary

    700,000 people in the UK have dementia, 250,000 of whom live in care homes. These individuals have complex mental health problems, disabilities and social needs, compounded by widespread prescription of harmful sedative drugs. Dementia is a national priority with a vast impact on Health and Social Care Services. The inconsistent quality of care, the poor management of mental health problems and the widespread overuse of sedative drugs are matters for serious concern (e.g.National Audit Office report 2007). The launch of the National Dementia Strategy (2009) and a parallel Department of Health report regarding the use of sedative drugs, provides an opportunity to move forward on a national basis to provide a better trained workforce that can improve the mental health of people with dementia living in care homes and reduce the use of sedative drugs. Our optimized programme (WHELD) will combine the most effective elements of existing approaches to develop a comprehensive but practical intervention. This will be achieved by training care staff to provide care that is focused on an understanding of the individual and their needs; and by using additional components such as exercise, activities and social interaction to improve mental health, reduce sedative drugs and also improve quality of life (QOL). The value of WHELD will be established in a 12 month clinical trial in 1000 people with dementia residing in 40 care homes. In parallel, WHELD will be tested in real clinical settings to identify and overcome any obstacles to making the treatment nationally available as an NHS intervention for care homes. An extensive and comprehensive dissemination programme of workshops, web and written communications and road-shows with health professionals, care professionals and commissioners is planned to achieve widespread implementation. This is extremely important, as no care home intervention has previously been implemented in real clinical practice. The programme will dovetail with more specialist NHS approaches for the treatment of severe mental health problems amongst care home residents.

    The overarching goal is to provide an effective, simple and practical intervention, which improves the mental health and reduces sedative drugs in people with dementia in care homes, and which can be rolled out nationally to all UK care homes as an NHS intervention. We will also find out whether the intervention improves QOL.

    Further information available at:

Types: Investments > €500k
Member States: United Kingdom
Diseases: Alzheimer's disease & other dementias
Years: 2011
Database Categories: N/A
Database Tags: N/A

Export as PDF